Total Payments
$6,979
2024 Payments
$2,194
Companies
36
Transactions
343
Medicare Patients
1,666
Medicare Billing
$229,202
Payment Breakdown by Category
Food & Beverage$6,736 (96.5%)
Education$243.39 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,736 | 340 | 96.5% |
| Education | $243.39 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,712 | 79 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,180 | 78 | $0 (2024) |
| GENZYME CORPORATION | $653.73 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $561.70 | 29 | $0 (2024) |
| Grifols USA, LLC | $418.87 | 9 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $226.59 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $198.18 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $181.00 | 3 | $0 (2024) |
| Broncus Medical | $177.07 | 1 | $0 (2019) |
| Mylan Specialty L.P. | $173.34 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,194 | 109 | AstraZeneca Pharmaceuticals LP ($550.14) |
| 2023 | $1,827 | 85 | GlaxoSmithKline, LLC. ($344.55) |
| 2022 | $1,516 | 69 | AstraZeneca Pharmaceuticals LP ($544.28) |
| 2021 | $453.33 | 29 | AstraZeneca Pharmaceuticals LP ($148.00) |
| 2020 | $171.45 | 10 | GlaxoSmithKline, LLC. ($90.40) |
| 2019 | $411.29 | 15 | Broncus Medical ($177.07) |
| 2018 | $152.87 | 10 | GlaxoSmithKline, LLC. ($68.23) |
| 2017 | $254.16 | 16 | GlaxoSmithKline, LLC. ($149.50) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Pulmonology | ||||||
| 12/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $97.71 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Neurology | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $67.99 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Narcoplepsy | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: HFCWO | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Immunology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 452 | 649 | $184,778 | $71,643 |
| 2022 | 13 | 686 | 898 | $278,947 | $84,646 |
| 2021 | 11 | 376 | 432 | $123,620 | $43,332 |
| 2020 | 5 | 152 | 249 | $186,364 | $29,582 |
Total Patients
1,666
Total Services
2,228
Medicare Billing
$229,202
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 111 | 217 | $85,715 | $33,397 | 39.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 130 | 130 | $62,790 | $24,115 | 38.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 73 | 155 | $11,160 | $4,263 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 31 | $8,825 | $3,440 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,566 | $3,030 | 40.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 37 | 43 | $3,182 | $1,262 | 39.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 16 | 16 | $2,160 | $818.40 | 37.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 20 | 20 | $1,780 | $691.40 | 38.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 16 | 16 | $1,600 | $624.96 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 124 | 295 | $116,525 | $44,029 | 37.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 85 | 85 | $41,055 | $15,749 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $16,868 | $6,669 | 39.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 61 | $13,340 | $5,169 | 38.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $10,396 | $4,052 | 39.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 49 | 64 | $4,607 | $1,818 | 39.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 15 | 17 | $24,964 | $1,788 | 7.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 16 | 16 | $22,444 | $1,612 | 7.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 37 | 42 | $3,080 | $1,249 | 40.6% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 36 | 40 | $1,784 | $709.31 | 39.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 67 | 67 | $6,700 | $689.62 | 10.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 66 | 67 | $7,976 | $591.51 | 7.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 67 | 68 | $9,208 | $520.12 | 5.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 84 | $33,180 | $13,511 | 40.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 60 | 60 | $28,980 | $11,581 | 40.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 47 | 47 | $13,583 | $5,588 | 41.1% |
About Dr. David Visco, MD
Dr. David Visco, MD is a Critical Care Medicine healthcare provider based in Cape May Court House, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104961564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Visco, MD has received a total of $6,979 in payments from pharmaceutical and medical device companies, with $2,194 received in 2024. These payments were reported across 343 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,736).
As a Medicare-enrolled provider, Visco has provided services to 1,666 Medicare beneficiaries, totaling 2,228 services with total Medicare billing of $229,202. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Cape May Court House, NJ
- Active Since 02/21/2007
- Last Updated 06/10/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104961564
Products in Payments
- DUPIXENT (Biological) $1,274
- BREZTRI (Drug) $606.80
- TRELEGY ELLIPTA (Drug) $492.03
- NUCALA (Biological) $457.43
- Prolastin-C Liquid (Biological) $418.87
- FASENRA (Biological) $383.59
- TEZSPIRE (Biological) $367.03
- AIRSUPRA (Drug) $188.45
- WAKIX (Drug) $170.62
- ARALAST (Biological) $149.09
- ANORO (Drug) $146.36
- YUPELRI (Drug) $135.31
- SYMBICORT (Drug) $129.18
- OFEV (Drug) $99.76
- Xolair (Biological) $97.20
- (8874) inCourage (Device) $93.59
- SMARTVEST (Device) $92.76
- PURIFIED CORTROPHIN GEL (Drug) $91.26
- BEVESPI AEROSPHERE (Drug) $88.28
- (AK6) Vest Therapy (Device) $86.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.